Thursday, October 24th
16:30-17:00 Tisagenlecleucel in relapsed/refractory Follicular Lymphoma – Update and 3 year RWE
Industry-supported Meet the Expert Session
by Novartis
17:00-17:15 Technical Break
17:15-17:45 CMV prophylaxis to treatment: update and current data 2024
Industry-supported Meet the Expert Session
by Takeda
17:45-18:00 Technical Break
18:00-18:30 ECP and Ruxolitinib combination in severe steroid-refractory acute GvHD
Industry-supported Meet the Expert Session
by Therakos
18:30 Welcome Reception
Friday, October 25th
08:00-08:15 Good Morning Coffee
08:15-08:30 Welcome Note
08:30-10:00 Session 1: Graft-versus-host disease (GvHD) Prophylaxis and Treatment
10:00-10:20 Coffee Break, Poster Viewing and Visit Exhibition
10:20-11:50 Targeting inflammation and fibrosis from the start – can belumosudil improve long-term outcomes in chronic GvHD?
Industry-supported Symposium
by Sanofi
11:50-12:00 Technical Break
12:00-13:30 Session 2: Acute Myeloid Leukemia (AML)
13:30-14:15 Lunch Break, Poster Viewing and Visit Exhibition
14:15-15:15 Controversy: Should all patients with FLT3-positive AML go to transplant?
Industry-supported Lunch Symposium
by Daiichi Sankyo
15:15-15:30 Short Break
15:30-17:00 Session 3: Acute Lymphoblastic Leukemia (ALL)
17:00-17:30 Coffee Break, Poster Viewing and Visit Exhibition
17:30-19:00 Session 4: Myelodysplastic Syndromes (MDS) and Myeloproliferative Neoplasms (MPN)
Saturday, October 26th
08:30-10:00 Session 5: Lymphoma and Myeloma
10:00-10:30 Coffee Break, Poster Viewing and Visit Exhibition
10:30-12:00 Session 6: GvHD Prevention and Treatment
12:00-12:45 Lunch Break, Poster Viewing and Visit Exhibition
12:45-14:15 Advancements in CMV-management post HSCT
Industry-supported Lunch Symposium
by MSD
14:15-14:30 Short Break
14:30-16:00 Session 7: Non-malignancies
16:00-16:30 Coffee Break, Poster Viewing and Visit Exhibition
16:30-17:30 Session 8: Myths and Facts around EBV post HSCT
17:30-17:45 Short Break
17:45-19:15 Session 9: Pediatrics
19:15 Poster Walk and Awards Session (Poster Area)
Sunday, October 27th
09:00-10:30 Session 10: Artificial Intelligence (AI) and Specific Cell Therapy
10:30-11:00 Coffee Break
11:00-12:30 Session 11: Graft Manipulation and Autoimmune Diseases
12:30 Closing Remarks